Sojournix, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms (NCT04278872) | Sojournix, Inc. | 2020-11-09 |
Track Sojournix, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.